Skip to content
Open Menu
Search for:
News & events
Insight & resources
Facilities
Careers
Contact
Drug substance
Back to main menu
Drug substance
Custom development
Process development & validation
Analytical development & validation
Custom manufacturing
Technology transfer
Manufacturing capabilities
Generic APIs
Product catalogue
Controlled substances
High potency APIs
Specialist technologies
Biocatalysis
Continuous flow
Controlled substances
Crystallization process development
High potency APIs
Solid state science
Material characterization
Drug product
Back to main menu
Drug product
Custom development
Formulation development
Analytical development & validation
Clinical supply
Custom manufacturing
Technology transfer
Manufacturing capabilities
Packaging
Conventional dosage forms
Solid dose
Semi-solid dose
Liquids
Specialized dosage forms
Fixed-dose combinations
Pediatric
Bi-layer tablets
Stick packs
Topicals
Controlled substances
Sterile & non-sterile
Solid state science
Material characterization
Analytical services
Back to main menu
Analytical services
Compendial testing
Microbiology
Cleanroom services
Release & QC testing
Extractables/leachables studies
Stability storage
Method development & validation
Material characterization
Elemental impurities
Impurity isolation, identification & characterization
Reference standard qualification
Bioanalytical & biopharmaceutical analysis
Biopharmaceutical Testing
Open Search
News & events
News
Search news
Post date
Post Date
Tags
Tags
All Tags
About (1)
analytical services (19)
APIs (1)
biocatalysis (1)
Cambrex (3)
Careers (1)
case study (20)
cGMP (1)
Chemistry (1)
Company (2)
Compounds (1)
Continuous flow (4)
Corporate Brochure (1)
Custom Development (1)
Development (1)
Drug product (12)
Drug substance (21)
Facilities (1)
HPAPIs (1)
information sheet (11)
Literature (4)
Manufacturing (1)
Meet our experts (1)
Opioids (1)
Resources (3)
Small Molecule (1)
Video (1)
Webcasts (1)
Webinar (3)
whitepaper (4)
By author
By Author
All Authors
Cambrex (99)
Dan McGinn (5)
Hannah McLachlan (36)
Leanne Buffery (2)
Natalee Campbell (3)
Advanced search
Year:
2017
5 Dec 2017
Cambrex Recognized for Support of Sustainability Program in Local High Schools
9 Nov 2017
Cambrex wins API development award at CPhI Worldwide for second consecutive year
8 Nov 2017
Cambrex invests in new small scale capacity at its Charles City, Iowa facility
3 Nov 2017
Gregory B. Brown M.D. Appointed to the Board of Directors of Cambrex Corporation
23 Oct 2017
Cambrex Adds Large Scale Manufacturing Capacity at Its Charles City, Iowa Facility
12 Oct 2017
Cambrex Invests in Generic API Development and Manufacturing Capabilities at Its Milan Site
26 Sep 2017
Cambrex opens API manufacturing facility and invests in supporting waste water treatment plant at its Karlskoga, Sweden site
30 Aug 2017
Cambrex Invests In New Analytical Development And Method Validation Laboratory At Its High Point, NC Facility
17 Aug 2017
Cambrex Surpasses ChemStewards® Requirements and Qualifies for SOCMA’s “Excellence” Ranking
8 Aug 2017
Cambrex Invests $24 Million in New Highly Potent API Manufacturing Capacity at its Charles City, Iowa Facility
Posts navigation
Older posts